Sida 1 från 68 resultat
FIELD OF INVENTION
This invention is directed to, inter alia, a composition comprising a synergistic combination of an omega-3 fatty acid with lycopene. More specifically, the present invention provides a composition comprising a synergistic combination of the aforementioned compounds, which may be
FIELD OF THE INVENTION
The present invention relates to the field of pharmacology and molecular medicine. More specifically, the invention relates to pharmaceutical compositions containing omega-3 oil in combination with an anti-inflammatory agent or a pharmaceutical agent that induces
TECHNICAL FIELD
The present invention relates to a novel anti-inflammatory compound.
BACKGROUND ART
Inflammatory disease, in the modern era, is one of the important disease fields for which countermeasures are necessary. Steroids, aspirin and ibuprofen, which are called nonsteroidal
FIELD OF THE INVENTION
The present invention provides highly purified omega-3 fatty acid formulations. Unit dosage forms of the omega-3 fatty acid formulations are provided herein. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune,
FIELD OF THE INVENTION
The present invention provides highly purified omega-3 fatty acid formulations. Unit dosage forms of the omega-3 fatty acid formulations are provided herein. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune,
FIELD OF THE INVENTION
The present invention relates to novel thiazolidinedione derivatives of omega-3 fatty acids used as insulin sensitizers for treating Type2 diabetes, obesity, hypertriglyceridemia, cardiovascular diseases, metabolic diseases, inflammation, cancer, renal anemia, Alzheimer's
It is an object of the invention to maximize the bioavailability and serving size of omega-3 long chain PUFA "O3-PUFA" by preparing an O3-PUFA delivery system that minimizes adverse enzymatic and oxidation reactions both from manufacturing to consumption of the delivery system and during consumption
CROSS-REFERENCE TO RELATED APPLICATION
This application is the U.S. national stage application of International Patent Application No. PCT/IT2010/000119, filed Mar. 18, 2010.
The present invention relates to ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids. More
The present invention relates to isotonic fat emulsions containing .omega.-3-fatty acids for parenteral application and the use thereof in post-aggression metabolism or in the treatment of chronic inflammatory diseases.
Fatty emulsions have the function to introduce fat into the organism in an
TECHNICAL FIELD
This invention relates generally to compositions and methods for inhibiting inflammation and/or adhesion formation in patients and, more specifically, to compositions containing omega fatty acids and methods for their administration.
BACKGROUND OF THE INVENTION
The prevention or
TECHNICAL FIELD
The present invention relates generally to compositions and methods for preventing and/or treating inflammation and pain in patients and, more specifically, to compositions containing omega fatty acids and spirulina and to methods for their administration.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to novel marine lipid compositions comprising combinations of omega-3 fatty acid rich functional phospholipids and omega-3 fatty acid rich triglycerides. In addition, food supplements, functional food, drugs and feed products comprising such
FIELD OF THE INVENTION
The present invention relates to novel marine lipid compositions comprising combinations of omega-3 fatty acid rich functional phospholipids and omega-3 fatty acid rich triglycerides. In addition, food supplements, functional food, drugs and feed products comprising such
FIELD OF THE INVENTION
The present invention relates to novel NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators to treat mild cases of Alzheimer's disease, to treat hypertriglyceridemia, to treat cardiovascular disease by reducing triglycerides and for use as
This application is a 371 of PCT/SE92/00333, filed May 19, 1992.
Introduction
The present invention relates to emulsions containing phospholipids of marine and/or synthetic origin with a high mount of (at least 30% (w/w) of its total fatty acid content) omega-3 (hereinafter written as) w3-fatty